Hemophilia Products — Revenue

How to read this metric

An increase indicates growing market adoption or higher patient utilization of the hemophilia product portfolio, while a decrease may signal increased competition, patent expirations, or shifts in treatment standards.

Detailed definition

Peer comparison

Comparable to revenue segments for rare disease or hematology franchises at other biopharmaceutical companies, often evaluated based on market share and patient access.